(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Greenrose Acquisition Corp., Super Micro Computer, and FAT Brands.

The three biggest losers today are iRobot, Evelo Biosciences, and Celsius Holdings.

Winners today

1. Greenrose Acquisition Corp. (GNRSW) – 100%

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

NASDAQ ended the session with Greenrose Acquisition Corp. jumping 100% to $0.00 on Friday while NASDAQ jumped 1.7% to $15,310.97.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 346.23%.

More news about Greenrose Acquisition Corp..

2. Super Micro Computer (SMCI) – 32.7%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer jumping 32.7% to $413.28 on Friday, after four successive sessions in a row of losses. NASDAQ rose 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $10.84.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 38.13. Meaning, the purchaser of the share is investing $38.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.32%.

More news about Super Micro Computer.

3. FAT Brands (FATBW) – 11.14%

FAT Brands Inc., a multi-brand restaurant company, acquires, develops, markets, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide. It owns restaurant brands, including Round Table Pizza, Marble Slab Creamery, Great American Cookies, Hot Dog on a Stick, Pretzelmaker, Fazoli's, Fatburger, Johnny Rockets, Elevation Burger, Yalla Mediterranean, Buffalo's Cafe and Buffalo's Express, Hurricane Grill & Wings, Ponderosa Steakhouse / Bonanza Steakhouse, Native Grill & Wings, and Twin Peaks. The company was incorporated in 2017 and is headquartered in Beverly Hills, California. FAT Brands Inc. operates as a subsidiary of Fog Cutter Holdings, LLC.

NASDAQ ended the session with FAT Brands jumping 11.14% to $3.99 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6%, now sitting on 425.64M for the twelve trailing months.

More news about FAT Brands.

4. Gyrodyne (GYRO) – 10.52%

Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.

NASDAQ ended the session with Gyrodyne jumping 10.52% to $9.98 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Gyrodyne has a trailing twelve months EPS of $0.22.

PE Ratio

Gyrodyne has a trailing twelve months price to earnings ratio of 45.36. Meaning, the purchaser of the share is investing $45.36 for every dollar of annual earnings.

Volume

Today’s last reported volume for Gyrodyne is 1 which is 99.72% below its average volume of 363.

More news about Gyrodyne.

5. Hall of Fame Resort & Entertainment Company (HOFV) – 8.62%

Hall of Fame Resort & Entertainment Company, a resort and entertainment company, doing business as the Pro Football Hall of Fame. It owns the premier sports, entertainment, and media enterprise surrounding the Pro Football Hall of Fame in Canton, Ohio. The company was founded in 2015 and is headquartered in Canton, Ohio.

NASDAQ ended the session with Hall of Fame Resort & Entertainment Company jumping 8.62% to $3.55 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Hall of Fame Resort & Entertainment Company has a trailing twelve months EPS of $-12.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.38%.

More news about Hall of Fame Resort & Entertainment Company.

6. Genasys (GNSS) – 8.33%

Genasys Inc., a communication company, designs, develops, and commercializes directed and multidirectional sound technologies, voice broadcast products, and location-based mass messaging solutions for emergency warning and workforce management worldwide. The company operates through two segments, Hardware and Software. It provides long range acoustic devices, such as acoustic hailing devices which are used to project sirens and audible voice messages; and Genasys Emergency Management, a unified software platform for cloud, on-premise or hybrid operations. The company also offers Integrated Mass Notification Solutions, including Genasys voice arrays, which project sirens and audible voice messages 60° – 360° with vocal clarity from close range to approximately 14 square kilometers; and GEM software to deliver SMS, text, email, and social media alerts to people at risk in defined geographic areas. It sells its products directly to governments, militaries, end-users, and commercial companies. The company was formerly known as LRAD Corporation. Genasys Inc. is based in San Diego, California.

NASDAQ ended the session with Genasys rising 8.33% to $1.69 on Friday while NASDAQ rose 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Genasys has a trailing twelve months EPS of $-0.5.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -43.69%.

Moving Average

Genasys’s worth is below its 50-day moving average of $1.72 and way below its 200-day moving average of $2.46.

Yearly Top and Bottom Value

Genasys’s stock is valued at $1.69 at 16:32 EST, way under its 52-week high of $4.07 and way above its 52-week low of $1.52.

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.3%, now sitting on 46.66M for the twelve trailing months.

More news about Genasys.

7. Wayfair (W) – 7.78%

Wayfair Inc. engages in the e-commerce business in the United States and internationally. The company provides approximately fourty million products for the home sector under various brands. It offers online selections of furniture, décor, housewares, and home improvement products through its sites, including Wayfair, Joss & Main, AllModern, Birch Lane, Perigold, and Wayfair Professional. The company was founded in 2002 and is headquartered in Boston, Massachusetts.

NYSE ended the session with Wayfair rising 7.78% to $54.86 on Friday, after two sequential sessions in a row of losses. NYSE jumped 0.61% to $16,718.08, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Wayfair has a trailing twelve months EPS of $-8.25.

Moving Average

Wayfair’s worth is higher than its 50-day moving average of $54.48 and higher than its 200-day moving average of $54.42.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 11.99B for the twelve trailing months.

Sales Growth

Wayfair’s sales growth is 1.4% for the present quarter and 2.1% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 91.8% and 63.7%, respectively.

More news about Wayfair.

8. Future FinTech Group (FTFT) – 6.93%

Future FinTech Group Inc., through its subsidiaries, operates a real-name block chain e-commerce platform that integrates block chain and internet technology in People's Republic of China. It operates through CCM Shopping Mall Membership, Sales of Goods, and Others segments. The company offers Chain Cloud Mall (CCM), an enterprise customer interactive and comprehensive shopping and sales service platform; NONOGIRL, a cross-border e-commerce platform; and DCON, a block chain-based application incubator and a digital payment system. It also engages in the development of block chain-based e-commerce and financial technology; and provides technical services and support for real name and blockchain based assets. The company was formerly known as SkyPeople Fruit Juice, Inc. and changed its name to Future FinTech Group Inc. in June 2017. Future FinTech Group Inc. is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Future FinTech Group jumping 6.93% to $0.90 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Future FinTech Group has a trailing twelve months EPS of $-0.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.54%.

Moving Average

Future FinTech Group’s value is way below its 50-day moving average of $1.04 and way below its 200-day moving average of $1.20.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Future FinTech Group’s EBITDA is 5.87.

More news about Future FinTech Group.

9. Dell (DELL) – 6.44%

Dell Technologies Inc. designs, develops, manufactures, markets, sells, and supports various comprehensive and integrated solutions, products, and services in the Americas, Europe, the Middle East, Asia, and internationally. The company operates through two segments, Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment provides traditional and next-generation storage solutions, including all-flash arrays, scale-out file, object platforms, hyper-converged infrastructure, and software-defined storage; and rack, blade, tower, and hyperscale servers. This segment also offers networking products and services that help its business customers to transform and modernize their infrastructure, mobilize and enrich end-user experiences, and accelerate business applications and processes; attached software and peripherals; and support and deployment, configuration, and extended warranty services. The CSG segment provides desktops, workstations, and notebooks; displays, docking stations, and other electronics; and third-party software and peripherals, as well as support and deployment, configuration, and extended warranty services. The company is also involved in the provision of cybersecurity technology-driven security solutions to prevent security breaches, detect malicious activity, respond rapidly when a security breach occurs, and identify emerging threats; originating, collecting, and servicing customer financing arrangements; and infrastructure-as-a-service solutions, as well as in the resale of VMware products and services. The company was formerly known as Denali Holding Inc. and changed its name to Dell Technologies Inc. in August 2016. Dell Technologies Inc. was founded in 1984 and is headquartered in Round Rock, Texas.

NYSE ended the session with Dell rising 6.44% to $83.46 on Friday while NYSE jumped 0.61% to $16,718.08.

Earnings Per Share

As for profitability, Dell has a trailing twelve months EPS of $3.61.

PE Ratio

Dell has a trailing twelve months price to earnings ratio of 23.12. Meaning, the purchaser of the share is investing $23.12 for every dollar of annual earnings.

Sales Growth

Dell’s sales growth is negative 11.5% for the ongoing quarter and 6.5% for the next.

Moving Average

Dell’s value is way above its 50-day moving average of $73.48 and way higher than its 200-day moving average of $59.38.

More news about Dell.

10. Histogen (HSTO) – 5.48%

Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.

NASDAQ ended the session with Histogen jumping 5.48% to $0.36 on Friday, following the last session’s downward trend. NASDAQ jumped 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Histogen has a trailing twelve months EPS of $-2.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -119.89%.

Yearly Top and Bottom Value

Histogen’s stock is valued at $0.36 at 16:32 EST, way below its 52-week high of $1.62 and way above its 52-week low of $0.28.

Volume

Today’s last reported volume for Histogen is 4353 which is 86.51% below its average volume of 32286.

More news about Histogen.

Losers Today

1. iRobot (IRBT) – -29.17%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot falling 29.17% to $16.73 on Friday, after two successive sessions in a row of losses. NASDAQ rose 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-11.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

iRobot’s EBITDA is -19.4.

Yearly Top and Bottom Value

iRobot’s stock is valued at $16.73 at 16:32 EST, way below its 52-week low of $28.23.

Volume

Today’s last reported volume for iRobot is 16743000 which is 1767.69% above its average volume of 896454.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, iRobot’s stock is considered to be overbought (>=80).

More news about iRobot.

2. Evelo Biosciences (EVLO) – -17.01%

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Evelo Biosciences dropping 17.01% to $0.06 on Friday, following the last session’s downward trend. NASDAQ rose 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Evelo Biosciences has a trailing twelve months EPS of $-15.64.

Moving Average

Evelo Biosciences’s worth is way below its 50-day moving average of $0.24 and way under its 200-day moving average of $3.37.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Evelo Biosciences’s EBITDA is -10.56.

More news about Evelo Biosciences.

3. Celsius Holdings (CELH) – -10.59%

Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. It also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened name; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery distributors and direct to retailers, include supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with Celsius Holdings falling 10.59% to $53.27 on Friday, after three sequential sessions in a row of losses. NASDAQ rose 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Celsius Holdings has a trailing twelve months EPS of $0.48.

PE Ratio

Celsius Holdings has a trailing twelve months price to earnings ratio of 110.98. Meaning, the purchaser of the share is investing $110.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.18%.

Volatility

Celsius Holdings’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.40%, a positive 0.92%, and a positive 2.66%.

Celsius Holdings’s highest amplitude of average volatility was 0.40% (last week), 2.62% (last month), and 2.66% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 104.4%, now sitting on 1.15B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Celsius Holdings’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 233.3% and 46.2%, respectively.

Previous days news about Celsius Holdings

• Celsius holdings inc. (celh) stock dips while market gains: key facts. According to Zacks on Thursday, 18 January, "Investors might also notice recent changes to analyst estimates for Celsius Holdings Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. ", "The latest trading session saw Celsius Holdings Inc. (CELH Quick QuoteCELH – Free Report) ending at $59.58, denoting a -0.48% adjustment from its last day’s close. "

More news about Celsius Holdings.

4. Gamida Cell Ltd. (GMDA) – -9.5%

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

NASDAQ ended the session with Gamida Cell Ltd. dropping 9.5% to $0.24 on Friday while NASDAQ rose 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Gamida Cell Ltd. has a trailing twelve months EPS of $-0.82.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1103.79%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 50% and 51.9%, respectively.

More news about Gamida Cell Ltd..

5. Canaan (CAN) – -8.7%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan falling 8.7% to $1.68 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.

Volume

Today’s last reported volume for Canaan is 11656300 which is 13.36% below its average volume of 13453700.

Volatility

Canaan’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.28%, a negative 0.81%, and a positive 6.55%.

Canaan’s highest amplitude of average volatility was 8.53% (last week), 8.30% (last month), and 6.55% (last quarter).

Sales Growth

Canaan’s sales growth is negative 33.6% for the ongoing quarter and negative 14% for the next.

Moving Average

Canaan’s worth is way under its 50-day moving average of $1.92 and way under its 200-day moving average of $2.22.

More news about Canaan.

6. Marathon (MARA) – -8.34%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon sliding 8.34% to $14.73 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.88%, a negative 1.47%, and a positive 6.15%.

Marathon’s highest amplitude of average volatility was 4.88% (last week), 7.99% (last month), and 6.15% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 92.5% and 200%, respectively.

Sales Growth

Marathon’s sales growth is 345.9% for the current quarter and 179.9% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be overbought (>=80).

More news about Marathon.

7. Fusion Pharmaceuticals (FUSN) – -8.21%

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is involved in the progressing of its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.

NASDAQ ended the session with Fusion Pharmaceuticals sliding 8.21% to $8.94 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Fusion Pharmaceuticals has a trailing twelve months EPS of $-1.61.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.16%.

Moving Average

Fusion Pharmaceuticals’s worth is way higher than its 50-day moving average of $6.19 and way above its 200-day moving average of $4.39.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fusion Pharmaceuticals’s EBITDA is -2.02.

Yearly Top and Bottom Value

Fusion Pharmaceuticals’s stock is valued at $8.94 at 16:32 EST, way under its 52-week high of $10.43 and way above its 52-week low of $2.31.

Sales Growth

Fusion Pharmaceuticals’s sales growth is 192.9% for the current quarter and negative 28.6% for the next.

More news about Fusion Pharmaceuticals.

8. Hoth Therapeutics (HOTH) – -7.3%

Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topical formulation for the treatment of mild to moderate rash and skin disorders associated with initial and repeat courses of tyrosine kinase inhibitor/epidermal growth factor receptor (EGFR) inhibitor therapy; HT-002 to treat illness associated with SARS-CoV-2 infection; HT-003D for the topical treatment in acne and psoriasis applications; HT-003IB to treat inflammatory bowel diseases; HT-004 for the treatment of asthma, atopic dermatitis, and other allergic diseases; HT-005 Z-PODS to treat cutaneous lupus erythematosus; HT-006 for treatment of multiple bacterial pathogens. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; and the University of Cincinnati. It also has a partnership agreement with Zylö Therapeutics Inc. co-develop a new topical treatment for patients with Cutaneous Lupus Erythematosu, a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life; and research collaboration agreement with Weill Cornell Medicine to continue the advancement of HT-003 for acne treatment research. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

NASDAQ ended the session with Hoth Therapeutics falling 7.3% to $1.27 on Friday while NASDAQ jumped 1.7% to $15,310.97.

Earnings Per Share

As for profitability, Hoth Therapeutics has a trailing twelve months EPS of $-4.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -100.65%.

Volume

Today’s last reported volume for Hoth Therapeutics is 138852 which is 49.86% below its average volume of 276962.

Moving Average

Hoth Therapeutics’s value is higher than its 50-day moving average of $1.24 and way under its 200-day moving average of $1.89.

More news about Hoth Therapeutics.

9. Evofem Biosciences (EVFM) – -7.14%

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.

NASDAQ ended the session with Evofem Biosciences sliding 7.14% to $0.04 on Friday, following the last session’s downward trend. NASDAQ jumped 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Evofem Biosciences has a trailing twelve months EPS of $38.97.

Yearly Top and Bottom Value

Evofem Biosciences’s stock is valued at $0.04 at 16:32 EST, way under its 52-week high of $8.00 and way above its 52-week low of $0.03.

More news about Evofem Biosciences.

10. Esports Entertainment Group (GMBL) – -6.61%

Esports Entertainment Group, Inc. operates as an online gambling company in Canada. The company offers esports entertainment, esports wagering, and iGaming and traditional sports betting services, as well as professional and amateur esports events. It also operates vie.gg, an online esports wagering website. The company was formerly known as VGambling, Inc. and changed its name to Esports Entertainment Group, Inc. in May 2017. Esports Entertainment Group, Inc. was incorporated in 2008 and is based in Birkirkara, Malta.

NASDAQ ended the session with Esports Entertainment Group falling 6.61% to $2.26 on Friday, after two consecutive sessions in a row of losses. NASDAQ jumped 1.7% to $15,310.97, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Esports Entertainment Group has a trailing twelve months EPS of $-4160.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19165.7%.

More news about Esports Entertainment Group.

Stay up to date with our winners and losers daily report